The global heart monitoring devices market valuation stands at US$ 25 billion in 2023 and is projected to reach US$ 45 billion by 2033. Worldwide demand for heart monitoring devices is forecasted to increase at a CAGR of 6% from 2023 to 2033.
After the University of Portsmouth announced a new ‘stealth’ polymer, Medical Plastics News spoke to Dr Farah El Mohtadi, senior lecturer in pharmaceutical sciences for the School of Pharmacy and Biomedical Sciences, for more information.
With Industry 4.0 quickly becoming an established reality, biopharmaceutical R&D, manufacturing and quality control facilities are implementing novel sensors and analysers that generate complex data.
Some of the latest figures from the Organisation of Economic Cooperation and Development (OECD), show that as little as 9% of the 460 million tonnes of plastic waste produced each year is recycled, while 22% is mismanaged and disposed of incorrectly.
The use of antimicrobial packaging in the healthcare industry is further fuelling product sales. Rising awareness of consumers on hygiene and packaging of medicines is aiding the market growth. Lavanya Maya, Future Market Insights, discusses.
The home diagnostics market has seen significant growth over the past few years, reinforced by the COVID-19 pandemic where many were encouraged to test at home for symptoms. Rachel Chapman, Owen Mumford discusses what this means for the sector.
According to the Recall Index by Sedgewick, medical device recalls have reached a record number over the last three years, with safety issues being the top reason. Chris Johnson, managing director at specialist bearing supplier SMB Bearings explains.
After Stratasys announced their collaboration with CollPlant on the development of a solution to bio-fabrication human tissues and organs, Medical Plastics News spoke to Erez Ben Zvi, vice president medical at Stratasys to find out more.
With the injectable drug delivery device market predicted to grow from $39.93 billion in 2022 to $43.54 billion in 2023, manufacturers must ensure continuity of supply for existing devices, John Swift, head of supply chain, Owen Mumford discusses.
Renewable and recycled drop-in solutions enable the production of more sustainable plastics for various applications, including sensitive medical ones.
Over the past 16 years Wideblue has worked with scores of medical device manufacturers on helping them bring their innovations to market. During this time two things have stood out — the importance of prototyping and testing.
